# Assessment of the Efficacy of Scorpion Antivenom Therapy in a Dose-response Manner, in Patients With Scorpionism

> **NCT06333834** · PHASE2,PHASE3 · COMPLETED · sponsor: **Selene Guadalupe Huerta Olvera** · enrollment: 56 (actual)

## Conditions studied

- Centruroides Envenomation

## Interventions

- **DRUG:** Traditional scorpion antivenom regimen
- **DRUG:** Serial dose of scorpion antivenom regimen

## Key facts

- **NCT ID:** NCT06333834
- **Lead sponsor:** Selene Guadalupe Huerta Olvera
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-15
- **Primary completion:** 2025-11-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2025-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06333834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06333834, "Assessment of the Efficacy of Scorpion Antivenom Therapy in a Dose-response Manner, in Patients With Scorpionism". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06333834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*